Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 9 | 2019 | 75 | 3.180 |
Why?
|
| Anemia, Sickle Cell | 8 | 2019 | 183 | 2.590 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2022 | 149 | 1.890 |
Why?
|
| Asthma | 7 | 2022 | 380 | 1.610 |
Why?
|
| Body Mass Index | 3 | 2017 | 854 | 0.910 |
Why?
|
| Pneumonia | 2 | 2021 | 54 | 0.900 |
Why?
|
| Influenza, Human | 2 | 2021 | 83 | 0.880 |
Why?
|
| Middle Aged | 27 | 2023 | 10129 | 0.770 |
Why?
|
| Aged | 19 | 2021 | 6741 | 0.730 |
Why?
|
| Male | 31 | 2023 | 20025 | 0.720 |
Why?
|
| United States | 18 | 2021 | 4223 | 0.710 |
Why?
|
| Intensive Care Units | 2 | 2017 | 59 | 0.710 |
Why?
|
| Hospitalization | 4 | 2021 | 388 | 0.700 |
Why?
|
| Nutrition Surveys | 6 | 2022 | 242 | 0.700 |
Why?
|
| Obesity | 3 | 2017 | 1067 | 0.700 |
Why?
|
| Aged, 80 and over | 13 | 2021 | 2379 | 0.690 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2019 | 29 | 0.690 |
Why?
|
| Vital Capacity | 2 | 2018 | 39 | 0.680 |
Why?
|
| Female | 31 | 2023 | 20969 | 0.670 |
Why?
|
| Sepsis | 2 | 2019 | 80 | 0.660 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 70 | 0.660 |
Why?
|
| Humans | 41 | 2023 | 37093 | 0.660 |
Why?
|
| Lung | 3 | 2017 | 446 | 0.650 |
Why?
|
| Adult | 24 | 2023 | 11712 | 0.640 |
Why?
|
| Nitric Oxide | 4 | 2022 | 316 | 0.630 |
Why?
|
| Hemodynamics | 2 | 2017 | 91 | 0.590 |
Why?
|
| Critical Illness | 1 | 2017 | 38 | 0.580 |
Why?
|
| Risk Factors | 10 | 2021 | 3562 | 0.570 |
Why?
|
| Tobacco, Smokeless | 1 | 2016 | 18 | 0.550 |
Why?
|
| Expiratory Reserve Volume | 1 | 2015 | 2 | 0.540 |
Why?
|
| Functional Residual Capacity | 1 | 2015 | 2 | 0.540 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2015 | 5 | 0.540 |
Why?
|
| Hospital Mortality | 4 | 2021 | 187 | 0.520 |
Why?
|
| Pulmonary Embolism | 1 | 2016 | 32 | 0.520 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 48 | 0.520 |
Why?
|
| Prevalence | 7 | 2017 | 1455 | 0.500 |
Why?
|
| Health Resources | 1 | 2015 | 32 | 0.500 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 101 | 0.500 |
Why?
|
| Cause of Death | 5 | 2019 | 156 | 0.450 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2026 | 0.440 |
Why?
|
| Health Status Disparities | 6 | 2021 | 642 | 0.420 |
Why?
|
| Dementia | 1 | 2013 | 131 | 0.420 |
Why?
|
| Smoking | 2 | 2020 | 940 | 0.400 |
Why?
|
| Comorbidity | 5 | 2018 | 623 | 0.390 |
Why?
|
| Survival Analysis | 4 | 2018 | 325 | 0.380 |
Why?
|
| Prognosis | 3 | 2018 | 739 | 0.360 |
Why?
|
| Sarcoidosis | 2 | 2019 | 11 | 0.330 |
Why?
|
| Survival Rate | 3 | 2017 | 311 | 0.280 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 905 | 0.270 |
Why?
|
| Wounds and Injuries | 2 | 2018 | 161 | 0.270 |
Why?
|
| Respiratory Function Tests | 2 | 2016 | 55 | 0.260 |
Why?
|
| Young Adult | 7 | 2019 | 4268 | 0.260 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2018 | 44 | 0.250 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 441 | 0.250 |
Why?
|
| Sex Distribution | 4 | 2019 | 215 | 0.240 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2015 | 63 | 0.230 |
Why?
|
| Exhalation | 3 | 2022 | 10 | 0.230 |
Why?
|
| Breath Tests | 3 | 2022 | 24 | 0.230 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 583 | 0.220 |
Why?
|
| Age Factors | 3 | 2017 | 1033 | 0.220 |
Why?
|
| Sex Factors | 3 | 2017 | 898 | 0.220 |
Why?
|
| Cognition | 2 | 2017 | 398 | 0.220 |
Why?
|
| Adolescent | 7 | 2019 | 5363 | 0.210 |
Why?
|
| Urbanization | 2 | 2019 | 11 | 0.210 |
Why?
|
| Child | 7 | 2019 | 3131 | 0.200 |
Why?
|
| Age Distribution | 3 | 2018 | 225 | 0.200 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 39 | 0.190 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 664 | 0.190 |
Why?
|
| Logistic Models | 2 | 2014 | 923 | 0.180 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 2019 | 5 | 0.180 |
Why?
|
| Databases, Factual | 1 | 2021 | 291 | 0.170 |
Why?
|
| Diarrhea | 2 | 2016 | 89 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2019 | 61 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 191 | 0.160 |
Why?
|
| Toxocara | 1 | 2017 | 1 | 0.160 |
Why?
|
| Toxocariasis | 1 | 2017 | 2 | 0.160 |
Why?
|
| Research | 1 | 2019 | 163 | 0.160 |
Why?
|
| Hypercalcemia | 1 | 2018 | 13 | 0.160 |
Why?
|
| Morbidity | 1 | 2018 | 91 | 0.160 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 23 | 0.150 |
Why?
|
| Pancreatitis | 1 | 2018 | 17 | 0.150 |
Why?
|
| Airway Obstruction | 1 | 2017 | 9 | 0.150 |
Why?
|
| Television | 1 | 2017 | 28 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 400 | 0.150 |
Why?
|
| District of Columbia | 1 | 2017 | 71 | 0.150 |
Why?
|
| Epoprostenol | 1 | 2017 | 25 | 0.150 |
Why?
|
| Gout | 1 | 2017 | 13 | 0.150 |
Why?
|
| Osteoarthritis | 1 | 2017 | 20 | 0.140 |
Why?
|
| Time Factors | 3 | 2017 | 1742 | 0.140 |
Why?
|
| Social Problems | 1 | 2016 | 14 | 0.140 |
Why?
|
| Forecasting | 1 | 2017 | 128 | 0.140 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 43 | 0.140 |
Why?
|
| Neck Pain | 1 | 2017 | 56 | 0.140 |
Why?
|
| Atrial Flutter | 1 | 2016 | 6 | 0.140 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 11 | 0.140 |
Why?
|
| Residual Volume | 1 | 2015 | 3 | 0.140 |
Why?
|
| Total Lung Capacity | 1 | 2015 | 6 | 0.130 |
Why?
|
| Length of Stay | 1 | 2017 | 185 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2015 | 34 | 0.130 |
Why?
|
| Echocardiography | 2 | 2017 | 144 | 0.130 |
Why?
|
| Sleep | 1 | 2017 | 152 | 0.130 |
Why?
|
| Low Back Pain | 1 | 2017 | 92 | 0.130 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 57 | 0.130 |
Why?
|
| Vital Statistics | 1 | 2014 | 7 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 974 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2023 | 1492 | 0.120 |
Why?
|
| Snoring | 1 | 2014 | 9 | 0.120 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 284 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2015 | 174 | 0.120 |
Why?
|
| Confidence Intervals | 1 | 2014 | 149 | 0.120 |
Why?
|
| Health Status | 1 | 2017 | 380 | 0.110 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2013 | 7 | 0.110 |
Why?
|
| Incidence | 1 | 2016 | 922 | 0.110 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 37 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 208 | 0.110 |
Why?
|
| Patient Discharge | 1 | 2013 | 93 | 0.110 |
Why?
|
| Mediterranean Region | 3 | 2017 | 6 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2017 | 309 | 0.110 |
Why?
|
| Heart Failure | 1 | 2016 | 235 | 0.110 |
Why?
|
| Child, Preschool | 4 | 2018 | 1418 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 325 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2014 | 381 | 0.110 |
Why?
|
| Health Surveys | 1 | 2014 | 373 | 0.100 |
Why?
|
| Pulmonary Fibrosis | 1 | 2012 | 31 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 204 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 53 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2012 | 124 | 0.100 |
Why?
|
| Mortality | 3 | 2018 | 145 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2013 | 753 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 494 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1067 | 0.090 |
Why?
|
| Infant | 3 | 2018 | 1046 | 0.090 |
Why?
|
| Death Certificates | 2 | 2018 | 12 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 1103 | 0.080 |
Why?
|
| Cost of Illness | 2 | 2018 | 76 | 0.070 |
Why?
|
| Middle East | 2 | 2017 | 18 | 0.070 |
Why?
|
| Life Expectancy | 2 | 2017 | 42 | 0.070 |
Why?
|
| Disabled Persons | 2 | 2018 | 65 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2017 | 894 | 0.060 |
Why?
|
| Fatigue | 1 | 2023 | 83 | 0.050 |
Why?
|
| New Jersey | 1 | 2021 | 15 | 0.050 |
Why?
|
| New York | 1 | 2021 | 71 | 0.050 |
Why?
|
| Disease Progression | 1 | 2023 | 601 | 0.050 |
Why?
|
| Acute Chest Syndrome | 1 | 2019 | 2 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2019 | 10 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2019 | 66 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 97 | 0.040 |
Why?
|
| Disease Management | 1 | 2019 | 61 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 1378 | 0.040 |
Why?
|
| Antibodies, Helminth | 1 | 2017 | 23 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 36 | 0.040 |
Why?
|
| Respiratory System | 1 | 2017 | 28 | 0.040 |
Why?
|
| Antigens, Helminth | 1 | 2017 | 34 | 0.040 |
Why?
|
| Djibouti | 1 | 2017 | 2 | 0.040 |
Why?
|
| Africa, Northern | 1 | 2017 | 3 | 0.040 |
Why?
|
| Somalia | 1 | 2017 | 3 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 217 | 0.040 |
Why?
|
| Spirometry | 1 | 2017 | 33 | 0.040 |
Why?
|
| Musculoskeletal Diseases | 1 | 2017 | 18 | 0.040 |
Why?
|
| Africa | 1 | 2016 | 76 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 237 | 0.040 |
Why?
|
| Cardiac Volume | 1 | 2015 | 4 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2015 | 20 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2015 | 30 | 0.030 |
Why?
|
| Poverty | 1 | 2017 | 348 | 0.030 |
Why?
|
| Heart Rate | 1 | 2015 | 253 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 646 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1369 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 481 | 0.030 |
Why?
|
| Aging | 1 | 2016 | 664 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 465 | 0.020 |
Why?
|
| Animals | 1 | 2017 | 15081 | 0.010 |
Why?
|